Publicaciones en las que colabora con MANUEL MENENDEZ GONZALEZ (20)

2025

  1. Assessing the association between common functional Nuclear Factor Kappa-b gene polymorphisms (NFKB1, NFKBIZ, NFKBIA) and Alzheimer´s disease

    Behavioural Brain Research, Vol. 476

2024

  1. NFKB1 variants were associated with the risk of Parkinson´s disease in male

    Journal of Neural Transmission, Vol. 131, Núm. 7, pp. 773-779

2022

  1. Smoking is associated with age at disease onset in Parkinson's disease

    Parkinsonism & related disorders, Vol. 97, pp. 79-83

2021

  1. Cancer in Parkinson's Disease: An Approximation to the Main Risk Factors

    Neurodegenerative Diseases, Vol. 21, Núm. 1-2, pp. 36-41

  2. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

    Neurobiology of Aging, Vol. 99, pp. 99.e15-99.e22

2014

  1. Alpha-synuclein transcript isoforms in three different brain regions from Parkinson's disease and healthy subjects in relation to the SNCA rs356165/rs11931074 polymorphisms

    Neuroscience Letters, Vol. 562, pp. 45-49

  2. MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects

    Journal of Molecular Neuroscience, Vol. 54, Núm. 4, pp. 830-836

  3. The screening of the 3′UTR sequence of LRRK2 identified an association between the rs66737902 polymorphism and Parkinson's disease

    Journal of Human Genetics, Vol. 59, Núm. 6, pp. 346-348

2013

  1. Mutational screening of PARKIN identified a 3′ UTR variant (rs62637702) associated with parkinson's disease

    Journal of Molecular Neuroscience, Vol. 50, Núm. 2, pp. 264-269

  2. Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls

    Journal of Neurology

  3. SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V

    Clinical Genetics, Vol. 83, Núm. 3, pp. 257-262

2012

  1. A search for SNCA 3′ UTR variants identified SNP rs356165 as a determinant of disease risk and onset age in Parkinson's disease

    Journal of Molecular Neuroscience, Vol. 47, Núm. 3, pp. 425-430

2011

  1. Amyloid precursor protein gene (APP) variation in late-onset alzheimer's disease

    Journal of Molecular Neuroscience, Vol. 45, Núm. 1, pp. 5-9

  2. Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease

    Brain Research, Vol. 1383, pp. 252-256

  3. Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy

    Neurogenetics

2010

  1. Analysis of the micro-RNA-133 and PITX3 genes in Parkinson's disease

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 153, Núm. 6, pp. 1234-1239

  2. FGF20 rs12720208 SNP and microRNA-433 variation: No association with Parkinson's disease in Spanish patients

    Neuroscience Letters, Vol. 479, Núm. 1, pp. 22-25

2008

  1. The Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease

    Alzheimer Disease and Associated Disorders, Vol. 22, Núm. 2, pp. 177-180

2007

  1. Myocyte enhancing factor-2A in Alzheimer's disease: Genetic analysis and association with MEF2A-polymorphisms

    Neuroscience Letters, Vol. 411, Núm. 1, pp. 47-51

2006

  1. A new de novo Notch3 mutation causing CADASIL

    European Journal of Neurology, Vol. 13, Núm. 6, pp. 628-631